We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 230

Other patent and trademark news

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • December 24 2013

Parliament has published amendments to the Patent Rules regarding becoming a patent agent and the Trademark Regulations regarding becoming a

Fact-specific issues relevant to calculating section 8 damages are decided

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • December 18 2013

This decision provides answers to certain issues that would allow the parties to calculate the loss under section 8 of thePM(NOC) Regulations that

Court of Appeal confirms that subsequent declaration of invalidity does not vary order of prohibition

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • December 18 2013

The issue to be determined by the Court of Appeal in this appeal was whether an Order of prohibition in a proceeding pursuant to the Patented

Motion for default judgment denied without affidavit evidence

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 28 2013

The Plaintiffs brought a motion for default judgment after no Statement of Defence was filed and no response to the Request to Admit was provided. The

Other industry news

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 28 2013

Health Canada has released of the Therapeutic Products Directorate Statistical Report 20122013 for the Patented Medicines (Notice of Compliance

Teva's allegation for section 8 damages not struck on appeal

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 28 2013

Pfizer appealed a decision refusing to strike Teva’s Statement of Claim to the Federal Court, but the appeal was dismissed because a de novo review

Order of prohibition granted in respect of one of two asserted patents

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 28 2013

Two patents were under consideration by the Court in this application brought pursuant to the Patented Medicines (Notice of Compliance) Regulations

ss. 53(2) of the Patent Act is a shield, not a sword

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 21 2013

Hoffmann-La Roche was denied the opportunity to correct a single word error in a patent’s disclosure pursuant to ss.53(2) of the Patent Act. The

Appeal of prohibition order dismissed

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 21 2013

The Federal Court issued an order prohibiting Teva from entering the market with its version of zoledronic acid until the expiration of two patents

Other news

  • Borden Ladner Gervais LLP
  • -
  • Canada, European Union
  • -
  • October 21 2013

Although the details have not been made official, it has been reported that the Canada-European Union Comprehensive Economic and Trade Agreement